[HTML][HTML] Niosomal drug delivery systems for ocular disease—Recent advances and future prospects

S Durak, M Esmaeili Rad, A Alp Yetisgin, H Eda Sutova… - Nanomaterials, 2020 - mdpi.com
The eye is a complex organ consisting of several protective barriers and particular defense
mechanisms. Since this organ is exposed to various infections, genetic disorders, and visual …

Liposomes in topical ophthalmic drug delivery: an update

R Agarwal, I Iezhitsa, P Agarwal, NA Abdul Nasir… - Drug …, 2016 - Taylor & Francis
Topical route of administration is the most commonly used method for the treatment of
ophthalmic diseases. However, presence of several layers of permeation barriers starting …

Nanotherapies for the treatment of ocular diseases

S Reimondez-Troitiño, N Csaba, MJ Alonso… - European Journal of …, 2015 - Elsevier
The topical route is the most frequent and preferred way to deliver drugs to the eye.
Unfortunately, the very low ocular drug bioavailability (less than 5%) associated with this …

Novel strategies for anterior segment ocular drug delivery

K Cholkar, SP Patel, AD Vadlapudi… - Journal of ocular …, 2013 - liebertpub.com
Research advancements in pharmaceutical sciences have led to the development of new
strategies in drug delivery to anterior segment. Designing a new delivery system that can …

MOF-based polymeric nanocomposite films as potential materials for drug delivery devices in ocular therapeutics

J Gandara-Loe, BE Souza, A Missyul… - … applied materials & …, 2020 - ACS Publications
Novel MOF-based polymer nanocomposite films were successfully prepared using Zr-based
UiO-67 as a metal–organic framework (MOF) and polyurethane (PU) as a polymeric matrix …

[HTML][HTML] Evaluation of sonication on stability-indicating properties of optimized pilocarpine hydrochloride-loaded niosomes in ocular drug delivery

K Owodeha-Ashaka, MO Ilomuanya, A Iyire - Progress in biomaterials, 2021 - Springer
Niosomes are increasingly explored for enhancing drug penetration and retention in ocular
tissues for both posterior and anterior eye delivery. They have been employed in …

Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: Ex-vivo permeation and in-vivo pharmacodynamic study

AE Eldeeb, S Salah, M Ghorab - Journal of Drug Delivery Science and …, 2019 - Elsevier
Glaucoma, a chronic disease of elevated intraocular pressure, is considered as the first
leading cause of blindness. Brimonidine tartrate (BRT), a hydrophilic drug with poor ocular …

Metal–organic frameworks as drug delivery platforms for ocular therapeutics

J Gandara-Loe, I Ortuño-Lizarán… - … applied materials & …, 2018 - ACS Publications
Metal–organic frameworks (MOFs) have been evaluated as potential nanocarriers for
intraocular incorporation of brimonidine tartrate to treat chronic glaucoma. Experimental …

[HTML][HTML] Nanotechnology for medical and surgical glaucoma therapy—a review

ML Occhiutto, RC Maranhão, VP Costa… - Advances in Therapy, 2020 - Springer
Glaucoma is the second leading cause of blindness worldwide. Even though significant
advances have been made in its management, currently available antiglaucoma therapies …

Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives

RK Sahoo, N Biswas, A Guha… - BioMed research …, 2014 - Wiley Online Library
With the recent advancement in the field of ocular therapy, drug delivery approaches have
been elevated to a new concept in terms of nonionic surfactant vesicles (NSVs), that is, the …